Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Elliott

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
Immunity|April 24, 2002
Optimization of the MHC class I peptide cargo is dependent on tapasinAnthony P Williams, Chen Au Peh, Anthony W Purcell, et al.
The Journal of Biological Chemistry|February 16, 2006
The crystal structure of H-2D(b) complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediateAnn Glithero, Jose Tormo, Klaus Doering, et al.
Immunotherapy Advances|March 22, 2021
Protective low-avidity anti-tumour CD8+ T cells are selectively attenuated by regulatory T cellsGessa Sugiyarto, David Prossor, Osman Dadas, et al.
The EMBO Journal|May 29, 2002
The oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I moleculesAntony N Antoniou, Stuart Ford, Magnus Alphey, et al.
Veterinary Parasitology|July 16, 2021
Comparative therapeutic efficacies of oral and in-water administered levamisole, piperazine and fenbendazole against experimental Ascaridia galli infection in chickensTeka Feyera, Isabelle Ruhnke, Brendan Sharpe, et al.
The Journal of Biological Chemistry|October 13, 2017
Direct evidence for conformational dynamics in major histocompatibility complex class I moleculesAndy van Hateren, Malcolm Anderson, Alistair Bailey, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinomaSamuel L Hill, Gessa Sugiyarto, Jack Harrington, et al.
European Journal of Immunology|October 18, 2011
CD8+ T-cell cross-competition is governed by peptide-MHC class I stabilityIan Galea, Jana Stasakova, Melanie S Dunscombe, et al.
Journal of Proteome Research|January 8, 2025
Comparative Analysis of Transcriptomic and Proteomic Expression between Two Non-Small Cell Lung Cancer SubtypesBen Nicholas, Alistair Bailey, Katy J McCann, et al.
Scientific Reports|October 21, 2015
Selector function of MHC I molecules is determined by protein plasticityAlistair Bailey, Neil Dalchau, Rachel Carter, et al.
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Immunity|April 24, 2002
Optimization of the MHC class I peptide cargo is dependent on tapasinAnthony P Williams, Chen Au Peh, Anthony W Purcell, et al.
The Journal of Biological Chemistry|February 16, 2006
The crystal structure of H-2D(b) complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediateAnn Glithero, Jose Tormo, Klaus Doering, et al.
Immunotherapy Advances|March 22, 2021
Protective low-avidity anti-tumour CD8+ T cells are selectively attenuated by regulatory T cellsGessa Sugiyarto, David Prossor, Osman Dadas, et al.
The EMBO Journal|May 29, 2002
The oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I moleculesAntony N Antoniou, Stuart Ford, Magnus Alphey, et al.
Veterinary Parasitology|July 16, 2021
Comparative therapeutic efficacies of oral and in-water administered levamisole, piperazine and fenbendazole against experimental Ascaridia galli infection in chickensTeka Feyera, Isabelle Ruhnke, Brendan Sharpe, et al.
The Journal of Biological Chemistry|October 13, 2017
Direct evidence for conformational dynamics in major histocompatibility complex class I moleculesAndy van Hateren, Malcolm Anderson, Alistair Bailey, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinomaSamuel L Hill, Gessa Sugiyarto, Jack Harrington, et al.
European Journal of Immunology|October 18, 2011
CD8+ T-cell cross-competition is governed by peptide-MHC class I stabilityIan Galea, Jana Stasakova, Melanie S Dunscombe, et al.
Journal of Proteome Research|January 8, 2025
Comparative Analysis of Transcriptomic and Proteomic Expression between Two Non-Small Cell Lung Cancer SubtypesBen Nicholas, Alistair Bailey, Katy J McCann, et al.
Scientific Reports|October 21, 2015
Selector function of MHC I molecules is determined by protein plasticityAlistair Bailey, Neil Dalchau, Rachel Carter, et al.
Pageof 14